Estimated reading time: 1 minute
Table of contents
Introduction
Cannabis Legalization in Kansas remains a contentious issue as lawmakers revisit the possibility of legalizing medical cannabis. Since 2021, Kansas legislators have explored reform initiatives, yet repeated efforts have stalled due to procedural roadblocks and partisan debates. With strong public support for medical cannabis, the 2025 legislative session could prove pivotal in breaking this impasse.
Legislative History and Challenges
In 2021, Kansas lawmakers made an early push for reform when House members voted 79-42 to advance a medical cannabis initiative. However, the momentum quickly faltered when Republican Senate President Ty Masterson opted not to call the bill for a vote in his chamber. Subsequent legislative attempts over the past three years have similarly stalled. During the last biennial session, the Kansas Senate Federal and State Affairs Committee tabled the debate, with Masterson dismissing the proposal as a “nonstarter.” He emphasized that any approach to medical cannabis must “protect our children,” expressing a willingness to consider only a highly controlled pilot program.
Interim Committee and Recent Developments
Following the adjournment of the previous session, lawmakers formed an interim committee on medical cannabis. Over two days in October, state officials, law enforcement, business leaders, and medical professionals provided their insights on the issue. Despite these efforts, the committee ultimately rejected a motion from Sen. Cindy Holscher, D-Overland Park, to endorse legalization heading into the 2025 session. “I just feel like we keep circling here by doing interim committees and never really moving forward on the issue,” Holscher commented. More recently, on February 19, Holscher attempted to attach an amendment—to include “medical cannabis” among the treatments allowed—to a bill focused on expanding terminally ill patient access to experimental drugs. However, this amendment did not succeed.
Public Opinion and Future Prospects
Despite the legislative hurdles, public sentiment in Kansas is in favor of medical cannabis reform. An Emerson College Polling survey released in October 2024 found that 73% of Kansas voters support allowing qualifying patients to access medical cannabis. As one of 24 states lacking citizen-initiated ballot measures, Kansas faces unique challenges in enacting reform. Nonetheless, the strong voter support makes Kansas a state “to watch” in 2025 as advocates continue to push for change.
Conclusion
The journey toward Cannabis Legalization in Kansas is marked by repeated setbacks and cautious legislative maneuvers. Yet, with growing public backing and persistent advocacy from reform-minded lawmakers, there is renewed hope for progress in the 2025 session. Kansas stands at a critical crossroads, and the coming months will be decisive in determining whether the state can finally overcome its longstanding obstacles and provide much-needed access to medical cannabis for its residents.
Cannabis Legalization Kansas 2025 FAQs
Recreational marijuana is still illegal in Kansas, so there are no recreational cannabis dispensaries in the state.
Medical marijuana is illegal in Kansas. The state is one of a few jurisdictions in the whole nation that has yet to legalize cannabis in one form or the other.
All Kansas residents can legally buy our broad spectrum of CBD gummies that don’t contain THC, CBD edibles like CBN gummies, CBD gummies for sleep, and melatonin gummies.
Kansas residents can legally purchase CBD products from physical stores or online. They can buy THC-free CBD products from CBD dispensaries, pharmacies, vape shops, grocery stores, and health food stores. Residents can also buy CBD products online from third-party markets or directly from a product brand.
In 2021, Kansas Attorney General Derek Schmidt clarified that Delta-8 THC is considered a controlled substance unless it’s made from industrial hemp and contains no more than 0.3% total THC. This has caused some retailers to pull Delta-8 products off their shelves to avoid legal trouble.
Delta-9 THC: Under the 2018 “Farm Bill,” hemp-derived products with no more than 0.3% Delta-9 THC are federally legal. Kansas follows this rule, meaning products like edibles and tinctures that meet this legal threshold are permitted in the state.
Delta 10 THC is federally legal in the United States and is legal in Kansas! According to state law, which is in line with federal law, Kansas has specifically legalized all Hemp products which contain an acceptable level of Delta 9-THC.
Aside from one minor exception, the purchase, growth, use, and possession of marijuana is illegal in Kansas. Getting caught with any amount carries the potential for jail time and fines, no matter how small. Kansas has no medical marijuana program in place, nor does it allow adult-use recreational marijuana.
Kansas legislators have debated medical cannabis during the session or in a special committee in 2021, 2022, 2023 and 2024. Yet cannabis is still illegal in Kansas as of 3/2025.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase. - Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City. - New York Cannabis Lounge License: Expert Guide to Compliance and Success
The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation. - The 2026 New York Execution Gap: Scaling Your Cannabis Business
The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion. - Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry. - Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.